is the fda banning tirzepatide 🚨There's been a lot of confusion lately, so let's clear this up… Compounded GLP-1 medications (like semaglutide and tirzepatide) are not banned entirely — but access changing. has ended Tirzepatide is NO longer in

Beyond regularity, fiber offers additional benefits that matter on GLP-1s

For instance, GLP-1 side effects like fatigue often occur shortly after starting the medication or adjusting the dose, and they usually improve within a few weeks

Semaglutide hits one receptor, Tirzepatide hits two, and Retatrutide hits three and in published trials Retatrutide has produced the largest reductions of the group

And it delivers: 16.7% average weight loss in 12 months Achieved using 66% less GLP-1 medication than industry norms 8 out of 10 members transition off meds without regaining weight That means lower total cost of care, reduced long-term pharmacy spend, fewer relapses and yo-yo dieting, and better employee satisfaction and retention